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Introduction 
The presence of nitrite (NO2-) and nitrate (NO3-) in bodily fluids has been known for 
some time.  Dietary studies carried out by Mitchell et al 1 at the beginning of the twentieth 
century established that the amounts of nitrate excreted in the urine are higher than those 
ingested with the food, suggesting that the excess nitrate must be a product of endogenous 
biosynthesis.  Later metabolic balance studies by Tannenbaum et al2,3 showed that this 
assumption was correct and provided unequivocal evidence for mammalian nitrate 
biosynthesis. Griess4, using his eponymous chemical test, showed that human saliva contains 
small quantities of nitrite and the detection of very high levels of nitrite in the urine of a 
volunteer, who happened to have contracted a fever, was the first indication that endogenous 
production of nitric oxide (NO) is part of the immune response. Nitrite is not normally present 
in urine, and it was Cruickshank and Moyes5 who realized that it originated from bacterial 
reduction of urinary nitrate, an observation that forms the basis of today’s dipstick tests for 
urinary tract infection. Shortly after the discovery by Moncada’s group that vascular 
endothelial cells produce NO from L-arginine6, Stuehr and Marletta reported that the same 
pathway accounts for the production of nitrite and nitrate by activated macrophages,7  and 
countless investigators have since used nitrite and nitrate to assess NO production in basic and 
translational research studies.  More recently, the ease with which nitrate is reduced to nitrite 
and nitrite converted into NO has occasioned interest in the role of plasma nitrite in vascular 
smooth muscle relaxation and the control of blood pressure and flow8, and possible 
therapeutic uses of nitrite.9,10   Subsequent animal experimental studies revealed that a number 
of organs are protected against ischemia/reperfusion-related tissue injury following systemic 
application of small amounts of nitrite11, suggesting further therapeutic uses.  Strangely, this 
renewed interest in nitrite/nitrate, together with emerging data suggesting possible new roles 
for these anions in physiology, coincides with the conclusion by the International Agency for 
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Research on Cancer that ‘ingested nitrate or nitrite under conditions that result in endogenous 
nitrosation is probably carcinogenic for humans’.12   The purpose of this review is neither to 
consider the physiological role of naturally occurring nitrite and nitrate in organs and bodily 
fluids or their usefulness as biomarkers of NO activity, nor to discuss their possible role as 
carcinogens, but to explore the uses of inorganic nitrite and nitrate in medicine, not only 
modern medicine but also medicine of the past.  It transpires that medical interest in these 
oxyanions of nitrogen is not new. 
 
Discovery and chemical properties 
 Nitrates, particularly potassium nitrate (known also as niter or nitre and salpeter), have 
been known since prehistoric times and, in the Middle Ages, natural deposits were 
commercially exploited.  The Chinese invented gunpowder around CE 800 and, with its 
appearance in Europe during the thirteenth century, potassium nitrate became strategically 
important. Demand increased further with the Agricultural Revolution of the nineteenth 
century and the use of nitrates as fertilizers. Natural sources were eventually supplemented by 
synthetically produced nitrate at the beginning of the last century.13 
Nitrite is present at trace levels in soil, natural waters, and plant and animal tissues. In 
pure form, nitrite was first made by the prolific Swedish chemist Scheele working in the 
laboratory of his pharmacy in the market town of Köping.  He heated potassium nitrate at red 
heat for half an hour and obtained what he recognised as a new ‘salt’.14  The two compounds 
(potassium nitrate and nitrite) were characterised by Péligot.15 
2KNO3    →     2KNO2    +    O2 
The release of oxygen from a substance known to alchemists as “aerial niter” since the times 
of Paracelsus16 explains the role of nitrates in gunpowder, rocket propellants and other 
explosives.  Sodium nitrite rapidly gained importance in the development of organic 
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chemistry during the nineteenth century when it was discovered that nitrous acid (HNO2) 
reacts with aromatic amines (ArNH2) to produce diazonium ions17, a highly important 
synthon for the dyestuffs industry and for synthetic organic chemistry generally: 
ArNH2    +    HNO2    +    H+     →     ArN=N+    +     2H2O 
The mechanism of such diazotisation reactions has been subject to extensive study18 and 
diazotisation may be responsible, in part, for the carcinogenic role of nitrite under certain 
conditions, in particular drug-nitrite interactions.19    
 Nitric acid (HNO3) is a strong acid and completely ionised at all biologically 
interesting pHs.  Although nitrous acid (HNO2) is a weak acid, with a pKa of 3.15,  it is also, 
at physiological pHs, completely dissociated, except in the stomach, on the surface of 
airways, within select cellular compartments such as the mitochondrial intermembrane space, 
endosomes, secretory vesicles, lysosomes and other acidic organelles, and on the skin.  
 
Nitrite as a vasodilator 
The scope of this review is limited to inorganic nitrite and nitrate, but interest in a medical 
role for inorganic nitrite was first aroused because of the spectacular success of organic 
nitrites, and related compounds, in the treatment of angina pectoris. Butter20, writing about the 
treatment of angina in 1791, gave no drug treatment and had little more to offer than 
recommending a tranquil life style. However, while working at the Edinburgh Royal 
Infirmary in the 1860s, Brunton noted that the pain of angina could be lessened by 
venesection and wrongly concluded that the pain must be due to elevated blood pressure.  As 
a treatment for angina the reduction of circulating blood by venesection was inconvenient.  
Therefore, he decided to try the effect on a patient of inhaling amyl nitrite, a recently 
synthesised compound and one that his colleague Gamgee21 had shown lowered blood 
pressure in animals.  The result was dramatic.22  Pain associated with an anginal attack 
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disappeared rapidly and the effect lasted for several minutes, generally long enough for the 
patient to recover by resting.  For a time amyl nitrite was the favoured treatment for angina 
but its volatility made it troublesome to administer and it was soon replaced by chemically 
related compounds that had the same effect but are less volatile.  The most popular 
replacement was glyceryl trinitrate (GTN), an organic nitrate better known as nitroglycerin.23 
The fact that this compound is highly explosive and a component of dynamite appears not to 
have been a problem.  In his textbook of 1897 Brunton24 lists a number of chemically related 
compounds that can be used in the treatment of angina.  The list includes not only amyl nitrite 
but propyl, ethyl and isobutyl nitrites, as well as GTN.  A similar list is provided by White25 
in his textbook of 1899.  GTN, a drug introduced into allopathic medicine thanks to extensive 
homeopathic studies by Hahnemann,26 occasioned greatest favour amongst practising 
physicians and by 1956, in a symposium on hypotensive drugs,27 it is the only drug of this 
type that is listed. GTN was first synthesized by Sobrero at the University of Torino in 1812 
and, considering the way in which he handled it, he was fortunate not to cause a fatal 
accident.28  He thought it too explosively violent to have any practical use.  Nobel, the highly 
successful Swedish entrepreneur, was able to moderate its action by incorporating it into 
kieselguhr to form dynamite.  It is largely from this invention the Nobel family fortune is 
derived.  Tragically, Nobel’s younger brother Emil was killed while working with GTN and 
this was a dark episode in Nobel’s life. Sobrero bitterly resented Nobel’s commercial success 
with what he saw as his invention, although Nobel always acknowledged his debt to 
Sobrero.29  It is a curious coincidence that by 1895 Nobel had developed angina and was 
prescribed GTN as treatment, but it is a happier coincidence that the 1998 Nobel Prize for 
Physiology or Medicine was awarded for the discovery of the role of NO as a signaling 
molecule in the cardiovascular system.  Now that NO is known to be an important 
vasorelaxant it is easy to see why drugs of this type act in the way they do.  Each is a substrate 
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for one or more enzyme systems, possibly located in the vascular wall, that convert it into 
nitrite and subsequently to NO. One such enzyme, a mitochondrial aldehyde dehydrogenase, 
has been purified and partially characterised.30 However, the contribution of this or other 
enzyme systems to the overall vasodilation by these drugs is difficult to assess since multiple 
metabolic pathways appear to act in concert.31 
 In view of the range of organic nitrites and related compounds that act as vasodilators 
it is not surprising that potassium and sodium nitrites were tested in this regard.  In 1880, 
Reichert and Mitchell32 published a very full account of the biological action of potassium 
nitrite on humans as well as animals.  At that time the value of amyl nitrite in the treatment of 
angina was severely compromised by the short duration of its effect and the search for an 
improved drug had begun.  The effect of potassium nitrite on the nervous system, brain, spinal 
cord, pulse, arterial blood pressure and respiration of healthy human volunteers was noted, as 
was the variability between individuals.  The most significant observation was that even a 
small dose of < 0.5 grains (~30 mg) given by mouth caused, at first, an increase in arterial 
blood pressure followed by a moderate decrease.  With larger doses pronounced hypotension 
ensued.  They also noted that potassium nitrite, however administered, had a profound effect 
on the appearance and oxygen carrying capacity of the blood.  They compared the biological 
action of potassium nitrite with that of amyl and ethyl nitrites and concluded, rather 
interestingly, that the similarity of action depends upon the conversion of organic nitrites to 
nitrous acid.  Similar observations to those of Reichert and Mitchell were made by Atkinson33 
and by Densham.34  Practicing physicians, including Hay35 and Leech36, examined the 
therapeutic value of inorganic nitrites as hypotensive drugs and noted that, although of slower 
onset, the therapeutic effect lasts much longer and they might be seen as superior drugs. They 
soon appeared in the Materia Medica of the time.  In 1906 the drug supplier Squibb sold a 1 lb 
bottle of sodium nitrite (sodii nitris) for one dollar37, and by the mid 1920s an injectable 
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solution of sodium nitrite became available (Nitroskleran; E.Tosse & Co., Hamburg) for the 
treatment of hypertension and vasospasm.38  Instructions for the use of sodium nitrite in the 
treatment of angina are given in Martindale’s Additional Pharmacopoeia and in the US 
National Dispensatory of 1905.39  A textbook on Materia Medica for medical students of 1921 
gives details of the appropriate dose40 but, by the middle of the twentieth century, its 
medicinal use had essentially ceased, largely because of adverse side effects.  Blumgarten41 
noted that sodium and potassium nitrites often caused nausea, belching, stomach ache and 
diarrhoea. While these side effects may have caused physicians to hesitate in prescribing 
sodium nitrite for angina another event precipitated inorganic nitrite’s fall from favour (see 
below). 
 Interest in the vasodilator properties of nitrite enjoyed a renaissance with the notion 
that nitrite may be involved in the regulation of local blood flow following conversion to NO 
by non-enzymatic mechanisms42,43  and an oxygen-sensitive nitrite-reductase44 and S-
nitrosothiol-synthase45 function of hemoglobin. Like NO, inhaled nebulized nitrite has been 
shown to be an effective pulmonary vasodilator46 and, along with organic nitrites47, suggested 
for potential use in neonatal pulmonary hypertension. While there is no doubt that appropriate 
pharmacological doses of nitrite can normalize elevated blood pressure48, the question as to 
whether or not physiological concentrations of nitrite are vasodilator-active is still a matter of 
debate.49,50 
Conversion of nitrite into NO and NO-related products 
In view of the close chemical connection between nitrite and NO it is tempting to assume that 
nitrite acts as a source of NO when functioning as a vasodilator. However, such conversion 
requires either strongly acidic conditions or enzymatic catalysis.  At low pH nitrous acid can 
give rise to the spontaneous generation of NO: 
2HNO2     →    H2O    +    N2O3 
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N2O3       →     NO     +    NO2 
While solutions of acidified nitrite have been used successfully to generate NO and induce 
vasorelaxation in isolated blood vessel studies,51 the same reaction mechanism has been 
proposed to explain nitrite’s biological action.52,53  However,  pHs at which this occurs are not 
generally found within living systems,54 with the exceptions mentioned above.  On the other 
hand, the enzyme xanthine oxidoreductase converts nitrite into NO when oxygen levels are 
low and this is a more likely course of action55 in the vascular system, at least under ischemic 
conditions.  In fact, recent data suggests that hypoxic NO formation from nitrite is carried out 
by multiple enzyme systems10 and occurs in virtually all tissues and organs (Feelisch et al., 
2006; unpublished data).  Independent of its reduction to NO, nitrite is converted into NO-
related products including S-nitrosothiols and NO-heme species at normal physiological pH 
and oxygen levels.56 While it cannot be excluded that some of the biological effects of nitrite 
may be mediated by nitrite itself, it is fair to assume that the majority of nitrite’s physiological 
and therapeutic actions that require conversion into NO and NO-related products involve 
enzymatic catalysis. 
 
Nitrite as an antidote for cyanide and hydrogen sulphide poisoning 
In popular literature cyanide (CN-) is considered to be the acme of human poisons.  In fact it 
is by no means the most poisonous substance generally available but it acts very rapidly and it 
is upon this that its reputation rests.  Large doses cause instant death and even with low doses 
the characteristic symptoms of cyanide poisoning (loss of consciousness, motionless eyes, 
dilated pupils, cold skin and sluggish pulse and respiration) appear within seconds.  In spite of 
the catastrophic consequences of an overdose, potassium cyanide was over many years used 
in medicine as a treatment for chest complaints,57 particularly a dry cough.58  It was not 
removed from the British Pharmacopoeia until 1945.   
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 By the end of the 19th century it was established that the toxicity of cyanide was due to 
interference with the process of cellular respiration.59  Keilin60 showed that cyanide reacts 
with the ferric heme of the enzyme cytochrome c oxidase, a vital link between the 
tricarboxylic acid cycle and formation of metabolic water causing inhibition of mitochondrial 
respiration.  As cyanide also reacts with methemoglobin61 it should be possible to prevent the 
reaction of cyanide with cytochrome c oxidase by massively increasing the concentration of 
methemoglobin in the blood.  Nitrite oxidizes the central iron atom of hemoglobin from the 
ferrous (Fe2+) to the ferric (Fe3+) state, producing methemoglobin and is, therefore, a potential 
antidote for cyanide poisoning.  The clinical use of nitrite was first proposed by Hug62 and is 
now universally used.  Sodium thiosulfate is also included in the antidote to provide a source 
of sulfur to aid the conversion of cyanide into thiocyanate by rhodanese.  The first cases of 
acute cyanide poisoning in humans to be treated with nitrite and thiosulfate were reported in 
1934.  One patient had ingested 5g potassium cyanide but recovered after being given 1.5g 
sodium nitrite and 18g sodium thiosulphate.63  In many countries nitrite is part of the cyanide 
antidote kit.  Nowadays patients are given an ampoule of amyl nitrite by inhalation or an 
intravenous injection of 3% sodium nitrite, followed by a slow injection of 50% sodium 
thiosulfate.64 
 Although formation of methemoglobin is generally accepted as the explanation of the 
efficacy of nitrite as an antidote, there is evidence to suggest that this is not the complete 
explanation.65,66   There may be alternative or additional routes whereby nitrite detoxifies but 
no details are available.67  Compounds that promote NO release in vivo (like bradykinin) 
modify cyanide toxicity.   Whether this is nitrite’s alternative mode of action in detoxification 
or just another source of nitrite from endogenous NO is, at this time, difficult to assess. 
Nitrite is also an efficacious antidote to poisoning by hydrogen sulphide (H2S), an 
occupational hazard with high lethality and long-term neurological sequelae in survivors. Like 
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NO and CO, low concentrations of H2S are produced endogenously and have vasodilator 
properties, but the physiological significance of its formation is currently unknown.68  Supra-
physiological concentrations of sulphide, as experienced after H2S inhalation, lead to rapid 
inhibition of mitochondrial respiration by reversible binding to the central iron atom of 
cytochrome c oxidase in place of oxygen, explaining why H2S poisoning shares many 
similarities with cyanide intoxication.69 Nitrite administration, which is superior to that of 
oxygen alone70 and often combined with hyperbaric oxygen therapy, is most effective when 
given immediately after H2S exposure.71 It is thought to act via induction of 
methemoglobinemia and subsequent binding of hydrosulfide anions (HS-) to the oxidized 
blood pigment, leading to inhibition of cytochrome c oxidase and re-institution of aerobic 
respiration in the tissues. While this mode of action appears reasonable the rather slow rate of 
methemoglobin formation by nitrite is inconsistent with the rapid recovery typically observed 
in the clinical setting suggesting, as with the treatment of cyanide poisoning, the involvement 
of additional mechanisms. Although nitrite has been known to have protective and antidotal 
effects against experimental sulphide poisoning in rodents for many years72 nitrite 
administration for H2S intoxication was introduced into human therapy only in the mid 
1970s.73  The recommended dosage regimen for nitrite in sulphide intoxication is identical to 
that established for the treatment of cyanide poisoning, i.e. initiation with inhalations of amyl 
nitrite followed by intravenous injection of 10 mL of a 3% solution of sodium nitrite.74  
 
Other medical uses of inorganic nitrite 
In view of nitrite’s success with angina it was tried for the treatment of other medical 
conditions.  Law75 recommended the administration of very large doses (20 grains or 1.3g) of 
sodium nitrite for the treatment of epilepsy.  Other physicians tried this and found the side 
effects were far too serious to continue with the treatment, with considerable consequences 
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for the therapeutic use of inorganic nitrite.  The toxic nature of such high doses was 
confirmed by Ringer and Murrell76 and they concluded that Law had been using an impure 
sample of sodium nitrite that was largely sodium nitrate.  They attempted to establish a safe 
dose but the reputation of sodium nitrite had suffered and, in view of the success of GTN, it 
disappeared from widespread use.  The final blow came when Magee19 reported that certain 
nitrosamines, which could be formed in the stomach by reaction between nitrite and naturally-
occurring secondary amines in food, are strongly carcinogenic in rodents.  Although these 
findings were quickly confirmed by others and have been extended to other animal species, a 
causal relationship between nitrite and nitrate exposure and human cancer has not been 
unequivocally demonstrated.77 Nevertheless, further medical use of nitrite ceased for decades, 
except as an antidote in emergencies, and maximal contaminant levels of nitrite and nitrate 
levels in drinking water and foods soon became strictly regulated in most countries 
worldwide. In light of the negative image nitrite has acquired over the years, it is somewhat 
surprising that the use of nitrite as an antibacterial agent in canned food has continued. More 
recently, the antimicrobial properties of nitrite that form the basis for its use in food 
preservation, have been explored for potential benefit in lung and skin diseases. 
 
Acidified nitrite 
Acidification is a prerequisite for nitrite to act as antimicrobial agent, suggesting (albeit not 
proving) that the active principle is NO. It has been known for some time that the nitrite found 
in human saliva originates from nitrate that is actively secreted into the oral cavity and gets 
partially reduced there by the local commensal bacterial flora.78 After swallowing nitrite ends 
up in the acidic environment of the stomach and the NO thus produced is thought to 
contribute to the antibacterial effects of gastric juice. Similarly, the nitrite produced from 
nitrate in sweat is believed to exert antimicrobial effects on the surface of the skin.79 Thus, 
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acidified nitrite may be a component of innate immunity at several locations on and within the 
body. Some of the attempts to capitalize on this insight point into potentially promising 
therapeutic directions, although few of these findings have made their way into the clinic.  
The effectiveness of acidified nitrite in killing antibiotic-resistant Pseudomonas 
bacteria might offer a possibility to eradicate a major cause for chronic lung infections in 
cystic fibrosis patients,80 provided a safe mode of administration was found.  The 
antimicrobial properties of NO can be exploited by dermal application of crèmes containing 
nitrite and an acidifying agent, e.g. ascorbic acid, for the treatment of a number of skin 
diseases.81  The same concept has been demonstrated to increase microcirculatory blood flow 
in Raynaud patients82,83 and accelerate wound healing.84 While the effects of acidified nitrite 
are typically ascribed to the generation of NO the possibility that part of the nitrite applied is 
absorbed and converted into NO-related products in the tissue cannot be excluded. 
 
Use of inorganic nitrate in medicine 
Although modern manuals of Materia Medica and pharmacopoeias state that potassium nitrate 
has no drug action other than acting as a diuretic (see below), historical records show that it 
has been used extensively in medicine over the years for the treatment of a number of 
conditions.  In view of the close chemical relationship between nitrite and nitrate we suggest 
that the value of inorganic nitrate in medicine is due, at least in part, to its conversion into 
nitrite during administration or contamination with nitrite because of the manner in which it 
was manufactured. 
 Niter occurs in natural deposits in desert regions.  Fairly large amounts are found in 
the north western provinces of China and it was well known to early Chinese alchemists.  
They called it xiao shi (salve-stone) and it was first recognised in the fourth century CE.  It 
was a component of some of the elixirs of immortality concocted by Daoist savants as they 
searched for a means of realising the Daoist ideal of life without death.85  Entirely by chance 
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they mixed it with sulfur and charcoal and thus created gunpowder, which was used by the 
Chinese not only for fireworks but also for civil engineering and warfare.  The first printed 
formula for gunpowder occurs in a Chinese manual of war that appeared in CE 1044.      
 One of the oldest accounts of the use of niter in Chinese medicine is a treatment of 
what appears to be angina in an eighth century Chinese manuscript uncovered at the Buddhist 
grotto of Dunhuang.86  The patient is instructed to take niter, hold it under the tongue for a 
time and then swallow the saliva.  The significance of the instructions is that under the 
tongue, even in a healthy mouth, there are nitrate-reducing bacteria that convert some of the 
nitrate into nitrite.78,87  So, if the patient follows the physician’s instructions fully, he or she 
will be taking in nitrite known to be a treatment for the alleviation of anginal pain. 
 Arab physicians were amongst the most advanced of the medieval period but there is 
no mention of niter in a book on cardiac drugs by Avicenna, born CE 980.  The first extant 
Arabic mention of niter occurs in a book by Kitab al-Jami’fi al-Adwiya al-Mufrada (Book of 
the Assembly of Medical Simples) finished by Abu-Muhammad al-Malaqi Ibn al-Baitar 
around CE 1240.  Niter was called Thalji al-Sin (Chinese snow), indicating the contact 
between Chinese and Arab civilisations.  It was about this time that Arabs started to use niter 
in gunpowder, as well as a component of prescriptions.    
 Niter does not occur naturally to any great extent in Europe and the efficacious use of 
niter in early European medicine is easier to understand if one realizes how the niter was 
produced.  When gunpowder became known in Europe (Roger Bacon mentions it in CE 1240) 
there was enormous demand for niter and much was shipped to Europe from India, where it 
occurs in natural deposits.  But the demand outstripped supply and indigenous manufacture 
was started.  It was made in plantations or ‘nitriaries’, particularly in France and Germany.  
Natural conditions were simulated by exposing heaps of decaying organic matter mixed with 
lime to atmospheric action.88 Nitrates appeared as efflorescences and were converted into the 
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potassium salt by reaction with potassium carbonate (potash).  There are two groups of 
bacteria responsible for this process: Nitrosomonas convert ammonia into nitrite and 
Nitrobacter convert nitrite into nitrate.89  It is quite possible that niter from nitriaries contained 
some nitrite, thus giving it medicinal value.  This is unlikely in niter from natural deposits as 
they are old and aerial oxidation will, over time, convert all the nitrite into nitrate.  So, the 
eighth century Chinese physician mentioned previously had to instruct the patient on how to 
generate nitrite but European physicians of the 14-17th centuries, using niter from a different 
source, could prescribe it without further refinement as there was nitrite there already.   
 However, such a prescription was rather hit-or-miss as the amount of nitrite present 
was a matter of chance.  In one of the most comprehensive accounts of the use of niter, 
methods of making it more effective are described.  The book, by Challoner, was printed in 
London in 1584 and entitled ‘A short discourse of the most rare and excellent vertue of 
nitre’.90  The spelling of the English is idiosyncratic (rather like that of modern students) as 
spelling was not fully standardised until the publication of Johnson’s dictionary in 1775.  
Challoner’s book is concerned mainly with the value of niter in treating various 
dermatological conditions (‘diseases of the skinne’), including ‘tawnie steynings, freckles, 
duskness and flegmatike evaporations’.  It will, he claims, ‘restore the skinne and complexion 
to the native bewtie’.  The key to understanding this claim lies in the first section of the book 
where the author tells his readers how to make niter more effective (‘yet more sharpe and 
subtile’).  He describes three ways and they all involve heating (called ‘calcination’ by 
Challoner).  That, of course, converts some of the niter into potassium nitrite and so, without 
realising it, Challoner anticipated the discovery of potassium nitrite by Scheele by nearly 200 
years.  As discussed above, nitrite has an antibacterial effect and accelerates wound healing, 
hence its effectiveness on infected skin blemishes (‘skales, scrabbes, skurffe, dandruffe, 
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pimples, tetters, bytes’ and so on).  Naturally-occurring nitrite in saliva has the same effect 
and explains, in part, why most animals instinctively lick a wound.91 
 Challoner does not stop with the application of niter to the skin.  He claims that it can 
be used ‘for uncumbring and clensing of the lunges’ and for the ‘remedie of hoarnesses, olde 
coughe and toughe coughe, weising in the windpipes’ and so on.  For this use he suggests 
making the niter into a pill and then ‘hold one of those pilles lounge under the tongue, to mixe 
thereof as much as may be with the moisture of the mouth … and lastlie swallow it’,  a 
procedure curiously reminiscent of the Chinese prescription and anticipating some of the 
work of Lundberg, Weitzberg, Cole and Benjamin.78 
 
Nitrate and the treatment of lung diseases 
For a time amyl nitrite was used for relieving patients suffering an asthma attack and, in a 
paper92 of 1891, other nitrites, including sodium nitrite, were suggested for this.  The author 
remarks that the use of nitrites is not the treatment of choice but that it is said to be beneficial, 
probably by virtue of its smooth muscle relaxing effects.  However, relief could be delivered 
even better by a procedure using nitrate rather than nitrite.  Blotting paper was soaked in a 
solution of niter and allowed to dry.  Squares of the paper were burnt in a jar and the patient 
inhaled the fumes. Apparently, this procedure was frequently successful in relaxing a 
bronchial spasm.  It was first published as a patent in 186793, is described in detail in the 
Encyclopædia Britannica of 191194  and occurred as recently as 1926 in the US 
Dispensatory.95 The products of thermal decomposition of niter include NO, NO2 and O296.  
As NO is a poor bronchodilator and NO2 is toxic it is difficult to see how inhalation of this 
mixture brings relief.  Possibly the combination has an effect greater than the sum of its parts.   
In addition to its use in asthma, sodium nitrate was given orally for the treatment of 
chronic bronchitis.97   It is unclear whether the apparent effectiveness of this treatment was 
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secondary to its conversion to nitrite causing bronchial relaxation and antibacterial effects or 
due to an effect of nitrate itself. 
 
Nitrates as diuretics 
Nitrates have been used as diuretics for centuries. One of the first descriptions of the medical 
use of potassium nitrate for the treatment of dropsy (edema) is found in Thomas Willis’ 
‘Pharmaceutice Rationalis’ of 1674.98 While it was long known that relatively large amounts 
(grams) were required to achieve effective diuresis, the dose-response relationship was first 
established in systematic “homeopathic provings” in 1825.99  Clear differences in potency 
exist between various nitrate salts,100 with ammonium nitrate being the most effective. Their 
mode of action was revealed by studies in dogs demonstrating an enhanced excretion of 
urinary chloride and sodium, resulting in a net loss of salt and water, due an increased 
glomerular filtration without an equivalent increase in tubular reabsorption.101,102  Whether 
these effects are mediated by formation of nitrite or NO is unknown. 
 Extensive animal and human studies by Keith, Whelan and Bannick103 confirmed the 
superiority of the ammonium over the sodium salt of nitrate. They also demonstrated that 
nitrates can potentiate the effects of other diuretics and that toxic symptoms are remarkably 
rare, even when administered in doses of 10-15 g daily for several weeks. Thus, ammonium 
nitrate was introduced as a new more effective diuretic in 1926 and used with great success 
for the treatment of various forms of edema in North America, in particular at the Mayo 
Clinic. After a time of exaggerated emphasis on possible toxic effects of nitrates during the 
preceding two decades, which lead physicians to use lower, inadequate doses, it looked as 
whether ammonium nitrate was there to stay as the diuretic of choice. What had triggered the 
fear of inducing severe cyanosis when employing potassium or sodium nitrate as diuretics 
before was the toxicity associated with the use of massive amounts of bismuth subnitrate for 
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diagnostic purposes,104 which is somewhat surprising since the toxicity of large amounts of 
nitrate was well known for a long time.105 Concerns about the safety of nitrates reached a new 
height with the appearance of case reports about transient methemoglobinemia following 
administration of ammonium nitrate.106,107  The reasons for these rare complications (which 
disappeared on discontinuation of nitrate therapy in most cases) remain unclear, but may have 
been due to either contamination of the nitrate salt with nitrite, renal insufficiency causing 
elevated circulating levels of nitrate or gastrointestinal disorders with enhanced reduction of 
nitrate to nitrite by the bacterial gut flora.108 With alternative diuretics in the form of organic 
mercurials available, the therapeutic use of nitrates as diuretics was abandoned by the mid 
1930s. 
 
Nitrate in other medicinal preparations 
The fact that most nitrate salts are readily water-soluble has been exploited to produce 
medicines that require quick dissolution or application in liquid form. Although the effects of 
most of these drugs (e.g., cerium and silver nitrate) have little to do with the amounts of 
nitrate they contain, application of large enough quantities can cause methemoglobinemia.109 
Presumably, the same holds true for the excessive use of toothpastes aimed at treating dental 
hypersensitivity, some of which contain up to 10% potassium nitrate, although no intoxication 
from this source is documented in the literature. 
 
Conclusions and outlook 
In spite of the widespread use of sometimes astonishing amounts of nitrite and nitrate for 
different indications in medicine of the past, little use is made of them in contemporary 
medicine (except as antidote and solubility-enhancer).  This is a result of several factors, some 
of which we have described in this review. Apart from the replacement by more modern and 
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effective medicines in some cases, the major driving force for this development appears to 
have been the fear fostered by discussions, both in the lay press and in the scientific literature, 
about the purported health risks of exposure to nitrite and nitrate. Reports about 
methemoglobinemia in infants caused by drinks or food prepared with nitrate-rich (and 
bacterially contaminated) well water and vegetables such as spinach, celery and carrots (“blue 
baby syndrome”), intentional and occupational intoxications in adults, increasing nitrate 
levels in soil and lakes due to fertilizer overuse and the formation of potentially carcinogenic 
N-nitrosamines all contributed to the negative image nitrite and nitrate have held in recent 
years. As a result, major efforts have been made to remove as much nitrite and nitrate as 
possible from our drinking water, to advocate nitrite substitution against other (often less 
effective) food preservatives and to establish cultivation conditions that result in crops with 
reduced levels of nitrate.  While possible long-term consequences of a chronically reduced 
intake of nitrite and nitrate on human health are unknown, doubts have been raised about the 
general health risk of nitrite/nitrate intake.77,110-112 Interestingly, the average dietary intake of 
nitrate roughly equals that produced by the endogenous production of NO.113 Thus, if nitrite 
was truly of concern to human health because of its propensity to form carcinogenic 
nitrosamines, then the human body would have a significant evolutionary design flaw because 
~5% of all ingested and endogenously produced nitrate eventually ends up as nitrite in the 
stomach, as pointed out by Archer110 (so far about “intelligent design”). In spite of the critical 
voices nitrite and nitrate’s image remains stigmatized.  
What appears to have the greatest potential to change our current conception about the 
risk and value of nitrite and nitrate is the most recent emergence of data on the physiological 
and pharmacological effects of relatively low concentrations/doses of nitrite. Previously 
considered a biologically inert oxidative decomposition product of NO, nitrite has been 
proposed to be a signalling molecule in its own right.56 Given its propensity for conversion 
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into NO and related species, unequivocal evidence for this role may be difficult to provide 
unless nitrite-specific signalling pathways were identified. Although speculative, it is possible 
that the nitrite-based reaction channels of contemporary mammalian cells are a vestige of 
earlier bacterial pathways and that the evolutionary more recent L-Arg:NO pathway utilizes 
signalling cascades originally evolved for nitrite, not the other way round. Regardless, 
surprisingly low amounts of nitrite have been demonstrated to exert potent cytoprotective 
effects against ischemia/reperfusion-related tissue damage in vivo10,11, an action possibly 
mediated by modulation of mitochondrial function.114 Nitrate, which has been proposed to 
contribute to the health-promoting effects of the Mediterranean diet115 has been demonstrated 
to inhibit platelet aggregation,116  to mildly lower blood pressure,117 to enhance gastric 
mucosal defense mechanisms108  and to reduce the oxygen cost of exercise.118  The latter is 
perhaps one of the most surprising of the more recent findings across the spectrum of nitrate 
actions. This particular observation may explain why an enhanced production of NO, which 
not only elevates blood flow and thus oxygen transport to tissues but leads to increased levels 
of circulating nitrite and nitrate, is crucial for the adaptation of life to the chronic hypoxia 
experienced at high altitude.119 Taken together, these results have shifted the attention away 
from toxic and vasodilator properties to a focus on metabolic effects. Moreover, they make 
one wonder to what extent inorganic nitrate may contribute to the effectiveness of organic 
nitrates in the setting of heart failure, for example.  
Although efforts are underway to assess the potential usefulness of inorganic nitrite in 
a number of clinical research studies at the US National Institutes of Health none of these are 
likely to wet the appetite of the pharmaceutical industry to invest substantial amounts of 
money into drug development because not only are intellectual property claims related to 
simple inorganic compounds legally difficult to defend, but the material itself is cheap and 
readily available. The situation may change if medicinal chemists came up with new prodrugs 
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that allowed targeted delivery of nitrite to specific tissues or organs or nitrite/nitrate was 
intelligently used as adjuvant to current therapeutics. Which of the many facets of nitrite and 
nitrate action is likely to form the basis for future pharmaceutical exploitation is difficult to 
predict at present. Although rational approaches to the pharmacological treatment of medical 
problems have a tendency to ridicule the wisdom of century-old folk medicine and condemn 
alchemist’s doing as quackery, there is much to learn from the past. In reviewing nitrite and 
nitrate’s therapeutic use over centuries it appears that some of the potential these simple 
compounds may hold for medical use have not been realized, often because the basis for some 
unwanted drug effects were not understood and thus could not be controlled at the time. But 
even if the scare factor continues to dominate the mainstream thinking for some more time, 
there is an obvious need for a careful reassessment of the health risks of nitrite and nitrate. If 
initiated soon, such activity may provide the necessary “activation energy” to overcome the 
fear and stimulate the development of new therapeutic principles that utilize pathways 
regulated by nitrite and nitrate.  
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